The news reporters obtained a quote from the research from Jagiellonian University, "The overall message from the research done to date is that various types of dermatitis frequently coexist. Atopy and contact allergy seem independent, while there is insufficient data to state upon the relationship between atopy and allergic contact dermatitis. Furthermore, it seems at present that atopy does not, whereas atopic eczema does constitute a risk factor for irritant contact dermatitis. The interplay between atopy and diseases from the spectrum of dermatitis and eczema is not fully understood; nevertheless, their coexistence and overlapping are not rare. Therefore, every patient with eczema - regardless of age, sex or atopic status - should undergo an extensive diagnostic programme including each atopic eczema, irritant contact dermatitis, allergic contact dermatitis, and protein contact dermatitis."
According to the news reporters, the research concluded: "Better definitions and well designed studies are necessary to achieve detailed information on the complex relationships between each atopy, atopic eczema, and the three contact dermatitides."
For more information on this research see: Contact dermatitis in atopic individuals. Current Opinion in Allergy and Clinical Immunology, 2012;12(5):491-497. Current Opinion in Allergy and Clinical Immunology can be contacted at: Lippincott Williams & Wilkins, 530 Walnut St, Philadelphia, PA 19106-3621, USA. (Lippincott Williams and Wilkins - www.lww.com; Current Opinion in Allergy and Clinical Immunology - journals.lww.com/co-allergy/pages/default.aspx)
Our news correspondents report that additional information may be obtained by contacting R. Spiewak, Jagiellonian University, Coll Med, Fac Pharm, Dept. of Expt Dermatol & Cosmetol, PL-30688 Krakow, Poland.
Keywords for this news article include: Krakow, Poland, Europe, Dermatitis, Dermatology, Allergy and Immunology, Eczematous Skin Diseases
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2012, NewsRx LLC
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.